Targeting the Temporal Dynamics of Hypoxia-Induced Tumor-Secreted Factors Halts Tumor Migration

Manjulata Singh1, Xiao-Jun Tian2,3, Vera S Donnenberg1,4

  • 1Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania.

Cancer Research
|April 7, 2019
PubMed

Insights

Targeting tumor-secreted factors halts cancer cell migration by disrupting a self-sustaining feedback loop. This approach is more effective than targeting hypoxia, offering a promising strategy for drug development.

Area of Science:

  • Oncology
  • Cell Biology
  • Biophysics

Background:

  • Tumor migration is a critical step in metastasis, yet the mechanisms driving migratory phenotypes remain incompletely understood, hindering drug development.
  • Microenvironmental factors, such as hypoxia, are known to influence tumor behavior, but their precise role in initiating and sustaining migration requires further elucidation.

Purpose of the Study:

  • To investigate the mechanistic basis of tumor size-induced migratory phenotypes using a novel 3D microtumor model.
  • To identify key tumor-secreted factors involved in promoting cell migration and to evaluate therapeutic strategies targeting these factors or hypoxia.

Main Methods:

  • Development and utilization of a 3D microtumor model allowing control over tumor size and microenvironment.
  • Analysis of tumor-secreted factors (e.g., MMP9, FN) and their role in inducing migratory phenotypes.
  • Mathematical modeling to elucidate the temporal dynamics of tumor progression and migration.
  • Experimental validation of therapeutic interventions targeting secreted factors and hypoxia.

Main Results:

  • Tumor size-induced hypoxia recapitulated migratory phenotypes in various cancer cell types.
  • Upregulation of tumor-secreted factors like MMP9 and FN was observed, correlating with clinical findings.
  • A two-stage mechanism was identified: hypoxia initiates migration, which is then sustained by a positive feedback loop of secreted factors.
  • Inhibition of tumor-secreted factors effectively halted migration, whereas hypoxia inhibition showed limited efficacy and high variability.

Conclusions:

  • Tumor migration is driven by a temporal interplay between hypoxia-induced initiation and self-sustained positive feedback loops of secreted factors.
  • Targeting tumor-secreted factors represents a robust therapeutic strategy to halt tumor migration, overcoming inter-tumor heterogeneity.
  • Understanding the temporal dynamics of the tumor microenvironment is crucial for developing effective anti-metastatic therapies.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.7K
Hypoxia01:23

Hypoxia

Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
2.0K
Transcription Elongation Factors02:35

Transcription Elongation Factors

Transcription elongation is a dynamic process that alters depending upon the sequence heterogeneity of the DNA being transcribed. Hence, it is not surprising that the elongation complex's composition also varies along the way while transcribing a gene.
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
13.6K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K